BFM
CLYM

Boothbay Fund Management’s Climb Bio CLYM Stock Holding History

Boothbay Fund Management’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$632K Buy
+92,297
New +$532K 0.01% 1207
2025
Q2 		– Sell
-53,662
Closed -$65.5K – 1833
2025
Q1 		$65.5K Hold
53,662
– – ﹤0.01% 1259
2024
Q4 		$96.6K Sell
53,662
-12
-0% -$43 ﹤0.01% 1295
2024
Q3 		$273K Buy
53,674
+22,964
+75% +$162K 0.01% 1293
2024
Q2 		$218K Buy
+30,710
New +$204K 0.01% 1262

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return